Enlivex ENLV
NASDAQ ENLV
$0.39 -0.04 (-8.37%)
At close: Oct 2, 2026 · 4:00 PM EDT

Enlivex (ENLV) Accumulated Expenses (2017 - 2026)

Updated

Enlivex (ENLV) reported Accumulated Expenses of $12.72 million for Q2 2026, up 356.6% from $2.79 million a year earlier.

Analysis

Enlivex (ENLV) Accumulated Expenses (2017 - 2026) Analysis & Trends

At the end of FY2025, Enlivex posted Accumulated Expenses of $5.21 million, up 83.2% from FY2024.

  • Accumulated Expenses has a three-year compound annual growth rate of 3.8% (FY2022 to FY2025).
  • By year, Accumulated Expenses came in at $2.85 million in FY2024 (-28.9%), $4 million in FY2023 (-14.1%) and $4.66 million in FY2022.
  • The Q2 2026 figure ranks as the highest quarterly Accumulated Expenses in data going back to Q4 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Enlivex 1.28 Mn -55.12 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.72 Mn
Dec 31, 2025 5.21 Mn
Jun 30, 2025 2.79 Mn
Dec 31, 2024 2.85 Mn
Dec 31, 2023 4.00 Mn
Dec 31, 2022 4.66 Mn
Dec 31, 2018 19,000.00
Dec 31, 2017 353,000.00
API Access

Enlivex Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ENLV&period=max&api_key=YOUR_API_KEY